Summit Therapeutics
Abingdon
About Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $1.8B
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:SMMT
- Website: smmttx.com
- Phone: +44 (0)1235 443 939
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/summit-therapeutics-93169 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.